EUCTR2010-022558-18-IT进行中（未招募）不适用
A pilot trial with clenbuterol in spinal and bulbar muscular atrophy (SBMA).
AZIENDA OSPEDALIERA DI PADOVA0 个研究点开始时间: 2012年9月28日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •1) Genetically confirmed SBMA male patients with more than one of the following symptoms: muscle weakness, muscle atrophy, bulbar palsy or hand tremor. 2) Patients able to walk independently along a flat corridor with or without the of a cane or similar equipment. 3) Patients who were 30 to 70 years old at the time of informed consent 4) Patients who gave written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) documented cardiac disease. 2) documented hypersensibility to beta2 agonists.
研究者
相似试验
已完成
3 期
Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in AsthmaAsthmaNCT00667407Sumitomo Pharma America, Inc.627
已完成
4 期
Continuous Levalbuterol for Treatment of Status Asthmaticus in ChildrenAsthmaNCT00124176Children's Hospital of Philadelphia81
已完成
2 期
Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral SclerosisAmyotrophic Lateral SclerosisNCT04245709Dwight Koeberl, M.D., Ph.D.25
已完成
2 期
A Trial of Wellbutrin for Crohn's DiseaseCrohn DiseaseNCT00126373Altschuler, Eric, M.D.1
已完成
2 期
A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic DermatitisModerate-to-severe Atopic DermatitisNCT04444752Suzhou Connect Biopharmaceuticals, Ltd.226